Unclaimed brand
Atia Vision’s OmniVu™ Modular Shape-Changing Intraocular Lens (IOL) Aims to deliver a premium solution that utilizes the natural accommodative mechanism of the eye to restore the full range of functional vision, with
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#1E73BE
Mariner
30, 115, 190
208, 73, 43
84, 39, 0, 25
#569FF7
Cornflower Blue
86, 159, 247
213, 91, 65
65, 36, 0, 3
#013D5A
Astronaut Blue
1, 61, 90
200, 98, 18
99, 32, 0, 65
Atia Vision, Inc. is a Campbell, California-based medical technology company and a Shifamed portfolio company focused on developing intraocular lenses to improve outcomes for people undergoing cataract surgery. Its lead product, the OmniVu™ Lens System, is an investigational modular, shape-changing IOL designed to use the eye’s natural accommodative mechanism to provide a broad range of functional vision, from near to distance, while aiming to minimize visual disturbances such as halos and glare.
The dual-optic design pairs a fluid-filled, shape-changing base placed in the capsular bag with a fixed-power front optic that docks into the base. Atia Vision says this configuration is intended to support predictable refractive outcomes and preserve natural vision quality, using conventional surgical techniques. The company is advancing OmniVu through clinical research; the U.
S. FDA granted approval in 2025 to begin a traditional feasibility clinical study in cataract patients, and first-in-human results were announced for presentation in 2023. OmniVu is for investigational use only and is not available for sale in any geography
